发明申请
US20080293744A1 Enantiomers of Selected Fused Pyrimidones and Uses in the Treatment and Prevention of Cancer
审中-公开
所选融合嘧啶酮及其用途在治疗和预防癌症中的对映体
- 专利标题： Enantiomers of Selected Fused Pyrimidones and Uses in the Treatment and Prevention of Cancer
- 专利标题（中）： 所选融合嘧啶酮及其用途在治疗和预防癌症中的对映体
-
申请号： US11573683申请日： 2005-08-16
-
公开(公告)号： US20080293744A1公开(公告)日： 2008-11-27
- 发明人: Brian Aquila , Michael Howard Block , Audrey Davies , Jayachandran Ezhuthachan , Timothy Pontz , Daniel John Russell , Marie-Elena Theoclitou , XiaoLan Zheng
- 申请人： Brian Aquila , Michael Howard Block , Audrey Davies , Jayachandran Ezhuthachan , Timothy Pontz , Daniel John Russell , Marie-Elena Theoclitou , XiaoLan Zheng
- 申请人地址： SE Sodertalje
- 专利权人： ASTRAZENECA AB
- 当前专利权人： ASTRAZENECA AB
- 当前专利权人地址： SE Sodertalje
- 国际申请： PCT/GB2005/003207 WO 20050816
- 主分类号： A61K31/519
- IPC分类号： A61K31/519 ; C07D513/04 ; A61P35/00
摘要：
This invention relates to novel compounds having the structural formula (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment or prophylaxis of cancer.
信息查询
IPC分类:
